Quantification of serum HBXAP DNA in lung cancer patients by quantitative fluorescent polymerase chain reaction

Molecular Biology Reports

Volumn 40, Issue 6, 2013, Pages 4091-4096

  Hou, Yu Lei ^a   Chen, Hui ^a   Ge, Ming Jian ^a   Li, Feng Zeng ^a   Xue, Cheng Jun ^a   Wu, Yan Feng ^a   Luo, Hai Xia ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Circulating DNA; Diagnostic efficacy; Hepatitis B virus x associated protein; Lung cancer

Indexed keywords

CYTOKERATIN; CYTOKERATIN FRAGMENT 21-1; DNA; NEURON SPECIFIC ENOLASE; SQUAMOUS CELL CARCINOMA ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; FLUORESCENT QUANTITATIVE POLYMERASE CHAIN REACTION; GENE; HBXAP GENE; HUMAN; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CASE-CONTROL STUDIES; DNA, NEOPLASM; FEMALE; FLUORESCENCE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; ROC CURVE; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

HEPATITIS B VIRUS;

EID: 84877776626     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2488-4     Document Type: Article

References (30)

1. Vogelstein B, Kinzler KW (2002) The genetic basis of human cancer, 2nd edn. McGraw-Hill, Toronto Health Professions Division (New York)
2. Davidson B, Trope CG, Wang TL, Shile M (2006) Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival. Gynecol Oncol 103:814-819
3. Mao TL, Hsu CY, Yen MJ, Giks B, Sheu JJ, Gabrielson R, Vang L, Cope RG, Kurman TL, Wang M (2006) Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma. Hum Pathol 37:1169-1175
4. Li Q, Dong Q, Wang E (2012) Rsf-1 is overexpressed in non-small cell lung cancers and regulates cyclinD1 expression and ERK activity. Biochem Biophys Res Commun 420:6-10
5. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37:646-650
6. Goebel G, Zitt M, Müller HM (2005) Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias. Dis Markers 21:105-120
7. Fleischhacker M, Schmidt B (2007) Circulating nucleic acids (CNAs) and cancer-A survey. Biochim Biophys Acta 1775:181-232
8. Dobrzycka B, Terlikowski SJ, Mazurek A, Kowalczuk O, Niklinska W, Chyczewski L, Kulikowski M (2010) Circulating free DNA, p53 antibody and mutations of K-ras gene in endometrial cancer. Int J Cancer 127:612-621
9. Lofton DC, Model F, DeVos T, Tetzner R, Distler J, Schuster M, Song X, Lesche R, Liebenberg V, Ebert M, Molnar B, Grützmann R, Pilarsky C, Sledziewski A (2008) DNA methylation biomarkers for blood based colorectal cancer screening. Clin Chem 54:414-423
10. Nakamoto D, Yamamoto N, Takagi R, Katakura A, Mizoe JE, Shibahara T (2008) Detection of microsatellite alterations in plasma DNA of malignant mucosal melanoma using genome amplification. Bull Tokyo Dent Coll 49:77-87
11. Yang YJ, Chen H, Huang P, Li CH, Dong ZH, Hou YL (2011) Quantification of plasma hTERT DNA in hepatocellular carcinoma patients by quantitative fluorescent polymerase chain reaction. Clin Invest Med 34:238-244
12. Ginzinger DG (2002) Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 30:503-512
13. Travis WD, Brambilla E, Mueller-Hermelink HK, Harris CC (2004) World health organization classification tumors of the lung, pleura, thymus and heart. IARC Press, Lyon, pp 10-20
14. Shih IM, Sheu JJ, Santillan A, Nakayama K, Yen RE, Bristow R, Vang R, Parmigiani G, Kurman RJ, Trope CG, Davidson B, Wang TL (2005) Amplification of chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma. Proc Natl Acad Sci USA 102:14004-14009
15. Tai HC, Huang HY, Lee SW, Lin CY, Sheu MJ, Chang SL, Wu LC, Shiue YL, Wu WR, Lin CM, Li CF (2012) Association of Rsf-1 overexpression with poor therapeutic response and worse survival in patients with nasopharyngeal carcinoma. J Clin Pathol 65:248-253
16. Chen TJ, Huang SC, Huang HY, Wei YC, Li CF (2011) Rsf-1/HBXAP overexpression is associated with disease-specific survival of patients with gallbladder carcinoma. APMIS 119:808-814
17. Fang FM, Li CF, Huang HY, Lai MT, Chen CM, Chiu IW, Wang TL, Tsai FJ, Shih IM, Sheu JJ (2011) Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlated with aggressive oral squamous cell carcinoma. Am J Pathol 178:2407-2415
18. Shibata T, Uryu S, Kokubu A, Hosoda F, Ohki M, Sakiyama T, Mastuno Y, Tsuchiya R, Kanai Y, Kondo T, Imoto I, Inazawa J, Hirohashi S (2005) Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features. Clin Cancer Res 11:6177-6185
19. Loyola A, Huang JY, LeRoy G, Hu S, Wang YH, Donnelly RJ, Lane WS, Lee SC, Reinberg D (2003) Functional analysis of the subunits of the chromatin assembly factor RSF-1. Mol Cell Biol 23:6459-6468
20. Vignali M, Hassan AH, Neely KE, Workman JL (2000) ATP-dependent chromatin-remodeling complexes. Mol Cell Biol 20:1899-1910
21. Flanagan JF, Peterson CL (1999) A role for the yeast SWI/SNF complex in DNA replication. Nucleic Acids Res 97:299-311
22. Cosma MP, Tanaka T, Nasmyth K (1999) Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle and developmentally regulated promoter. Cell 97:299-311
23. Daichi M, Chen X, Guan B, Nakagawa S, Yano T, Taketain YJ, Fukayama M, Wang TL, Shih LM (2011) Rsf-1(HBXAP) expression is associated with advanced stage and lymph node metastasis in ovarian clear cell carcinoma. Int J Gynecol Pathol 30:30-35
24. Catarino R, Ferreira MM, Rodrigues H, Coelho A, Nogal A, Sousa A, Medeiros R (2008) Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer. DNA Cell Biol 27:415-421
25. Shi GL, Hu XL, Yu SD, Song CX (2005) The value of serum tumor marker in the diagnosis of lung cancer. Chin J Oncol 27:299-301
26. Sai S, Ichikawa D, Tomita H, Ikoma D, Tani N, Ikoma H, Kikuchi S, Fujiwara H, Ueda Y, Otsuji E (2007) Quantification of plasma cell-free DNA in patients with gastric cancer. Anticancer Res 27:2747-2752
27. Schwarzenbach H, Alix-Panabières C, Müller L, Letang N, Vendrell JP, Rebillard X, Pantel K (2009) Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clin Cancer Res 15:1032-1038
28. Paci M, Maramotti S, Bellesia E, Formisano D, Albertazzi L, Ricchetti T, Ferrari G, Annessi V, Lasagni D, Carbonelli C, Franco SD, Brini M, Sgarbi G, Lodi R (2009) Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer. Lung Cancer 64:92-97
29. Ellinger J, Wittkamp V, Albers P, Perabo FE, Mueller SC, Ruecker AV, Bastian PJ (2009) Cell-Free circulating DNA: diagnostic value in patients with testicular germ cell cancer. J Urol 181:363-371
30. Zhong XY, Ladewig A, Schmid S, Wight E, Hahn S, Holzgreve W (2007) Elevated level of cell-free plasma DNA is associated with breast cancer. Arch Gynecol Obstet 276:327-331